Brilliant....whats not to like about this presentation especially with the focus of "targeting human neurodegenerative diseases" headlining the first slide.
My only query is the meetings would have greater impact if they had the MEND top line results when talking to potential investors/partners. Who knows perhaps they are about to drop.
Well done PAA...concise and to the point. "The Team" certainly reads well with the new appointments
Brilliant....whats not to like about this presentation...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.00M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.3¢ | $112.4K | 570.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 71364 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 457262 | 6 |
View Market Depth
| Last trade - 15.59pm 05/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |